SCHEMBL4968538

SCHEMBL4968538

C[Si](C)(C)CCC(O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18668243 0.75
SCHEMBL13071274 0.75
SCHEMBL27994254 0.74
SCHEMBL10660072 0.73
SCHEMBL483389 0.69
SCHEMBL1042 0.65
SCHEMBL13198079 0.65
SCHEMBL5719652 0.65 TSHR (0.38)
SCHEMBL4341315 0.65
SCHEMBL18533315 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606277-B8 IMIDAZOL-4-YL-ETHYNYL-PYRIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-10-15 EP disclosed
EP-1606277-A1 IMIDAZOL-4-YL-ETHYNYL-PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-12-21 EP disclosed
CN-1612856-A 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof AVENTIS PHARMA SA (FR) 2005-05-04 CN disclosed
WO-2004080998-A1 IMIDAZOL-4-YL-ETHYNYL-PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-09-23 WO disclosed
EP-0354322-A2 Antidiabetic alpha-substituted phosphonates AMERICAN CYANAMID COMPANY (US) 1990-02-14 EP disclosed